http://www.newsweek.com/new-alopecia-treatment-drug-hair-growth-baricitinib-fda-phase-3-trial-study-1693645

A researcher has hailed "exciting" results from a study into a treatment for the hair loss condition alopecia areata.

A relatively common condition, alopecia areata is thought to affect 1 in every 500 to 1,000 people in the United States, and is one of many recognized types of alopecia.